GPT Healthcare (Small Cap) Share Target 2026, 2027 To 2035
|
GPT Healthcare Limited |
|||
|
Price: ₹147.24 (-0.63%) | ||
| 52 Week Low: ₹115.00 52 Week High: ₹185.00 |
|||
| Market Capital: 1,102.07 Crore (Small-cap) | |||
| Healthcare -> Medical Care Facilities | |||
Share Price HistoryGPTHEALTH FinancialsTomorrow TargetYearly TargetsDividend HistoryNo BonusNo Split
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: GPT Healthcare Share Price Target For 2026
- 1.1.1: GPT Healthcare Share Price Target Table For 2026
- 1.1.2: Short-Term Technical Outlook
- 1.2: GPT Healthcare Share Price Target For 2027
- 1.2.1: GPT Healthcare Share Price Target Table For 2027
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: GPT Healthcare Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
- 3: GPT Healthcare Brief Company Overview
- 4: GPT Healthcare Financial Performance
- 4.0.1: Is GPT Healthcare A Good Buy For Long Term?
GPT Healthcare, a Small Cap company in the Medical Care Facilities Industry showing 1.7% quarterly revenue growth with 11.9% profit margin.
To predict the GPT Healthcare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
GPT Healthcare Share Price Target For 2026
The line chart displays the monthly closing prices of GPT Healthcare with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for GPT Healthcare shares in 2026, see the table below.
GPT Healthcare Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 158.79 (+7.84%) | Volatility: ATR T1 |
| 2026 Target 2 | 153.94 (+4.55%) | Volatility: BB Upper |
| 2026 Target 1 | 147.30 (+0.04%) | Trend: EMA9 |
| Current Price | 147.24 | GPT Healthcare's share price as of 15 Jun 2026 |
| Stop Loss 1 | 140.44 (-4.62%) | Trend: SMA50 |
| Stop Loss 2 | 139.14 (-5.51%) | Trend: SMA200 |
| Stop Loss 3 | 136.00 (-7.64%) | Volatility: BB Lower |
Short-Term Technical Outlook
Current Technical Position: GPT Healthcare is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 50-day moving average at ₹140.44 serves as the nearest technical reference point.
Historical Returns: 3-month: +19.68% | 6-month: +4.37% | 1-year: -1.29%
GPT Healthcare Share Price Target For 2027
The line chart displays the monthly closing prices of GPT Healthcare with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for GPT Healthcare shares in 2027, see the table below.
GPT Healthcare Share Price Target Table For 2027
| Level | Value | Analysis |
|---|---|---|
| 2027 Target 3 | 158.79 (+7.84%) | Volatility: ATR T1 |
| 2027 Target 2 | 153.94 (+4.55%) | Volatility: BB Upper |
| 2027 Target 1 | 147.30 (+0.04%) | Trend: EMA9 |
| Current Price | 147.24 | GPT Healthcare's share price as of 15 Jun 2026 |
| Stop Loss 1 | 140.44 (-4.62%) | Trend: SMA50 |
| Stop Loss 2 | 139.14 (-5.51%) | Trend: SMA200 |
| Stop Loss 3 | 136.00 (-7.64%) | Volatility: BB Lower |
Long-Term Technical Outlook
52-Week Range Analysis: GPT Healthcare is currently trading at 46.1% of its 52-week range (₹115 - ₹185).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: -1.29% | 3-year: -22.71% | 5-year: -22.71%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
GPT Healthcare Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹147.24 | ||
| 2026 | ₹171.94 | +16.775332790003% | ₹174.52 |
| 2027 | ₹206.98 | +20.379202047226% | ₹210.08 |
| 2028 | ₹233.54 | +12.832157696396% | ₹237.04 |
| 2029 | ₹281.67 | +20.608889269504% | ₹285.90 |
| 2030 | ₹324.96 | +15.369048886995% | ₹329.83 |
| 2031 | ₹387.04 | +19.103889709503% | ₹392.85 |
| 2032 | ₹426.41 | +10.172075237702% | ₹432.81 |
| 2033 | ₹437.57 | +2.6171994090195% | ₹444.13 |
| 2034 | ₹472.43 | +7.9667253239482% | ₹479.52 |
| 2035 | ₹481.34 | +1.8859936921872% | ₹488.56 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
GPT Healthcare Brief Company Overview
GPT Healthcare Limited: A Comprehensive Healthcare Provider GPT Healthcare Limited, established in 1989, is a reputable healthcare provider in India under the brand name ILS Hospitals. The company boasts a diverse range of medical services, including: Internal...
medicine and diabetology Nephrology (renal transplants) Surgery (laparoscopic and general) Gynecology and obstetrics Critical care Gastroenterology Orthopedics and joint replacement Interventional cardiology Neurosciences Pediatrics Diagnostic services Neonatology GPT Healthcare's commitment to delivering high-quality healthcare is evident in its modern facilities and experienced medical staff.GPT Healthcare Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,337.49 Crore | Market valuation of GPT Healthcare's shares. |
| Revenue (TTM) | 401.81 Crore | Total revenue generated by GPT Healthcare over the past twelve months. |
| Net Income (TTM) | +47.75 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 13.58% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 11.88% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+1.7% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-0.1% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
13.97 | Company's total debt divided by total shareholder equity. |
| Total Debt | 30.54 Crore | Sum of GPT Healthcare's current & long-term financial obligations. |
| Total Cash | 19.03 Crore | Total amount of liquid funds available to GPT Healthcare. |
Is GPT Healthcare A Good Buy For Long Term?
GPT Healthcare, a small-cap stock with a market capitalization of ₹1337.49 crore, presents a mixed picture. While it boasts a healthy profit margin of 11.88% (net profit ₹47.75 crore on ₹401.81 crore revenue in TTM), its recent performance is underwhelming: a -13.87% return in the past three months and flat returns over the past year and longer periods. The low debt of ₹30.54 crore (Q1 2024-25) and cash balance of ₹19.03 crore are positive. However, given the lack of significant growth and recent negative returns, it's currently rated as an average buy for long-term investors. Further analysis is recommended before committing significant capital.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
